A Risk Model Developed based on Homologous Recombination Deficiency Genes for Evaluating the Drug Sensitivity and Prognostic Prediction of Lung Adenocarcinoma
The HRD-based RiskScore played a crucial role in LUAD development, showing a strong potential to serve as a prognostic indicator for LUAD. Our findings contributed to the diagnosis of LUAD and its treatment.
Authors
- Jiashun Li (ORCID: https://orcid.org/0000-0001-7463-2500)
- Weiwei Shao (ORCID: https://orcid.org/0000-0002-2691-0542)
- Lingling Hong (ORCID: https://orcid.org/0000-0003-3227-3209)
Institutions
- Twelfth Guangzhou City People's Hospital (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2024-10-02
- DOI
- https://doi.org/10.2174/0109298673333745240927074414
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00